| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| LDN-193189 HCl |
LDN-193189 HCl |
1062368-62-0 |
詳細
|
| Hexanoic acid,3-(aminomethyl)-5-methyl-, (3R)- |
R-普瑞巴林 |
148553-51-9 |
詳細
|
| Mc-Val-Cit-PAB |
MC-Val-Cit-PAB |
159857-80-4 |
詳細
|
| Monomethylauristatin E |
一甲基澳瑞他汀 E |
474645-27-7 |
詳細
|
| CNX-774 |
CNX-774 |
1202759-32-7 |
詳細
|
| Fmoc-Val-Cit-PAB |
Fmoc-Val-Cit-PAB |
159858-22-7 |
詳細
|
| LDC1267 |
LDC1267 |
1361030-48-9 |
詳細
|
| Boc-Dap-NE |
BOC-DAP-NE |
160800-65-7 |
詳細
|
| 9a-(4-chlorobenzyl)-7-hydroxy-4-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1,2,9,9a-tetrahydro-3H-fluoren-3-one |
CMP8 |
851107-28-3 |
詳細
|
| DOTA-HYNIC-PSMA(inhibitor) |
|
|
詳細
|
| SU6656 |
SU 6656 |
330161-87-0 |
詳細
|
| 2-CHLORO-5-FORMYL-4-PICOLINE |
6-氯-4-甲基吡啶-3-甲醛 |
884495-38-9 |
詳細
|
| PLERIXAFOR |
普樂沙福 |
110078-46-1 |
詳細
|
| NSC 632839 |
NSC632839hydrochloride |
157654-67-6 |
詳細
|
| YO-01027 (Dibenzazepine) |
二苯并氮卓 |
209984-56-5 |
詳細
|
| (2,5-dimethylthiophen-3-yl)boronic acid |
2,5-二甲基噻吩-3-硼酸 |
162607-23-0 |
詳細
|
| SCH772984 |
(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)對二氮己環(huán)-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺 |
942183-80-4 |
詳細
|
| 4-amino-2-chloronicotinaldehyde |
4-氨基-2-氯煙醛 |
338452-92-9 |
詳細
|
| 6-Bromo-2-methylpyridine-3-carboxaldehyde |
6-溴-2-甲基吡啶-3-甲醛 |
926293-55-2 |
詳細
|
| R1487 |
SY-R1487 |
449808-64-4 |
詳細
|
| VR23 |
VR23 |
1624602-30-7 |
詳細
|
| FIIN-3 |
FIIN-3 |
1637735-84-2 |
詳細
|
| RK-33 |
RK-33 |
1070773-09-9 |
詳細
|
| HYNIC-Tyr3-Octreotide |
|
|
詳細
|
| Akti-1/2 |
1,3-二氫-1-[1-[[4-(6-苯基-1H-咪唑并[4,5-G]喹喔啉-7-基)苯基]甲基]-4-哌啶基]-2H-苯并咪唑-2-酮 |
612847-09-3 |
詳細
|
| LY-411575 |
(AS)-N-[(1S)-2-[[(7S)-6,7-二氫-5-甲基-6-氧代-5H-二苯并[B,D]氮雜卓-7-基]氨基]-1-甲基-2-氧代乙基]-3,5-二氟-ALPHA-羥基苯乙酰胺 |
209984-57-6 |
詳細
|
| NSC-144303 |
108477-18-5 |
108477-18-5 |
詳細
|
| LDN-193189 |
LDN-193189 |
1062368-24-4 |
詳細
|
| 2-AMino-3-forMyl-4-chloropyridine |
2-氨基-4-氯煙醛 |
884004-48-2 |
詳細
|
| Tideglusib |
4-芐基-2-(萘-1-基)-[1,2,4]噻二唑烷-3,5-二酮 |
865854-05-3 |
詳細
|
| MMAD |
單甲基澳瑞他汀 D |
203849-91-6 |
詳細
|
| Mc-Val-Cit-PAB-MMAE |
VCMMAE |
646502-53-6 |
詳細
|
| poziotinib |
波齊替尼 |
1092364-38-9 |
詳細
|
| K-Ras(G12C) inhibitor |
K-RAS(G12C) INHIBITOR 12 |
1469337-95-8 |
詳細
|
| DOTA-Tyr3-Octreotide |
依多曲肽 |
204318-14-9 |
詳細
|
| Val-Cit-PAB-MMAE |
VAL-CIT-PAB-OH |
644981-35-1 |
詳細
|
| YC-1 |
利非西呱 |
170632-47-0 |
詳細
|
| (+)-MK 801 hydrogen maleate |
(+)-MK 801 順丁烯二酸鹽 |
77086-22-7 |
詳細
|
| Rhodamine 123 |
羅丹明 123 |
62669-70-9 |
詳細
|
| 2-Bromo-5-formyl-3-methylpyridine |
2-溴-3-甲基-5-甲?；拎?/td>
| 885167-81-7 |
詳細
|
| PD98059 |
2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮 |
167869-21-8 |
詳細
|
| MK 0557 |
MK 0557 |
328232-95-7 |
詳細
|
| Mc-Val-Cit-PAB-PNP |
馬來酰亞胺基己酰-L-纈氨酸-L-瓜氨酸對氨基芐醇 對硝基苯基碳酸脂 |
159857-81-5 |
詳細
|
| FMoc-Val-Cit-PAB-MMAE |
FMOC-VAL-CIT-PAB-MMAE |
1350456-56-2 |
詳細
|
| MG-132 |
蛋白酶體抑制劑 |
133407-82-6 |
詳細
|
| 4-BENZYLOXYBUTYRIC ACID |
4-芐氧基丁酸 |
10385-30-5 |
詳細
|
| Hispidin |
6-[(1E)-2-(3,4-二羥基苯基)乙烯基]-4-羥基-2H-吡喃-2-酮 |
555-55-5 |
詳細
|
| Bz-Arg-Et |
N-苯甲酰基-L-精氨酸 |
971-21-1 |
詳細
|
| AMI-1 |
猩紅酸鈉鹽 |
20324-87-2 |
詳細
|
| 2-Pyridineacetic acid, 6-methyl- (9CI) |
6-甲基吡啶-2-乙酸 |
92917-49-2 |
詳細
|
| 1-(AMINOMETHYL)CYCLOPROPANECARBOXYLIC ACID |
1-(氨基甲基)環(huán)丙烷羧酸 1HCL |
139126-45-7 |
詳細
|
| (R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide |
2(4-環(huán)丙基苯基)-N[(1R)- 1 -[5 -(2,2,2-三氟乙氧基)吡啶-2-基]乙基]乙酰胺 |
953778-63-7 |
詳細
|
| HYNIC-PSMA(inhibitor) |
HYNIC-PSMA(inhibitor) |
|
詳細
|
| 6-bromo-4-chlorothieno[3,2-d]pyrimidine |
6-溴-4-氯噻吩[3,2-D]嘧啶 |
225385-03-5 |
詳細
|
| Dp44mT |
2-(二-2-吡啶基亞甲基)-N,N-二甲基肼基硫代甲酰胺 |
152095-12-0 |
詳細
|
| Refametinib |
瑞法替尼 |
923032-37-5 |
詳細
|
| BAY 80-6946 |
2-氨基-N-[2,3-二氫-7-甲氧基-8-[3-(4-嗎啉基)丙氧基]咪唑并[1,2-C]喹唑啉-5-基]-5-嘧啶甲酰胺 |
1032568-63-0 |
詳細
|
| 6-BroMo-4-Methyl-pyridine-3-carbaldehyde |
6-溴-4-甲基煙醛 |
926294-07-7 |
詳細
|
| Mc-MMAE |
馬來酰亞胺基己酰-單甲基澳瑞他汀 E |
863971-24-8 |
詳細
|
| APY29 |
APY29 |
1216665-49-4 |
詳細
|
| 4-(dimethylamino)-4-phenylcyclohexan-1-one |
西博帕多中間體 |
65619-20-7 |
詳細
|
| (-)-MK 801 hydrogen maleate |
(-)-MK 801 順丁烯二酸鹽 |
121917-57-5 |
詳細
|
| Hoechst 34580 |
HOECHST 34580 |
23555-00-2 |
詳細
|
| Dolastatin 10 |
尾海兔素10 |
110417-88-4 |
詳細
|
| AMG-47a |
4-甲基-3-[2-[[2-(4-嗎啉基)乙基]氨基]-6-喹唑啉基]-N-[3-(三氟甲基)苯基]苯甲酰胺 |
882663-88-9 |
詳細
|
| FH535 |
2,5-二氯-N-(2-甲基-4-硝基苯基)苯磺酰胺 |
108409-83-2 |
詳細
|
| MMAF |
一甲基澳瑞他汀 F |
745017-94-1 |
詳細
|
| Voxtalisib |
VOXTALISIB |
934493-76-2 |
詳細
|
| Fmoc-3vvd-OH |
FMOC-3AA-OH |
863971-44-2 |
詳細
|
| Tariquidar |
N-[2-[[4-[2-(6,7-二甲氧基-3,4-二氫-1H-異喹啉-2-基)乙基]苯基]氨基甲?；鵠-4,5-二甲氧基苯基]喹啉-3-甲酰胺 |
206873-63-4 |
詳細
|
| 5-CHLORO-2-(CHLOROMETHYL)PYRIDINE |
2-氯甲基-5-氯吡啶 |
10177-24-9 |
詳細
|
| MK-2206 2HCl |
MK-2206 2HCl |
1032350-13-2 |
詳細
|
| Emd1214063 |
特泊替尼 |
1100598-32-0 |
詳細
|
| Dorsomorphin 2HCl
（BML-275 2HCl） |
BML-275 |
1219168-18-9 |
詳細
|
| BAY85-3934 |
MOLIDUSTAT |
1154028-82-6 |
詳細
|
| 5-(2-amino-4-oxo-3-(2-(trifluoromethyl)phenyl)-3,4-dihydroquinazolin-6-yl)-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide |
5-(2-AMINO-4-OXO-3-(2-(TRIFLUOROMETHYL)PHENYL)-3,4-DIHYDROQUINAZOLIN-6-YL)-N-(2,4-DIFLUOROPHENYL)-2-METHOXYPYRIDINE-3-SULFONAMIDE |
1384097-27-1 |
詳細
|
| (1R)-1-[5-(2,2,2-trifluoroethoxy)-2-pyridyl]ethanamine |
(R)-1-(5-(2,2,2-三氟乙氧基)吡啶-2-基)乙胺 |
953780-33-1 |
詳細
|
| DOTA-PSMA(inhibitor) |
|
|
詳細
|
| (E)-3-[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyano-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]prop-2-enamide |
3-[4-[[2,4-二(三氟甲基)芐基]氧基]-3-甲氧基苯基]-2-氰基-N-(5-三氟甲基-[1,3,4]噻二唑-2-基)丙烯酰胺 |
725247-18-7 |
詳細
|
| 3,5-diamino-N-(N'-benzylcarbamimidoyl)-6-chloropyrazine-2-carboxamide,hydrochloride |
3,5-二氨基-N-[(E)-氨基(芐基氨基)亞甲基]-6-氯-2-吡嗪甲酰胺鹽酸鹽(1:1) |
161804-20-2 |
詳細
|
| 4-cyclopropylphenylacetic acid |
4-環(huán)丙基苯乙酸 |
40641-90-5 |
詳細
|
| EAI045 |
EAI-045 |
1942114-09-1 |
詳細
|
| CeMMEC13 |
1790895-25-8 |
1790895-25-8 |
詳細
|
| Saccharin 1-methylimidazole (SMI) |
糖精1-甲基咪唑 |
482333-74-4 |
詳細
|
| CeMMEC1 |
440662-09-9 |
440662-09-9 |
詳細
|
| 2-(3,6-diacetyloxy-2,7-dichloro-9H-xanthen-9-yl)benzoic acid |
2,7-二氯二氫代熒光黃二醋酸 |
4091-99-0 |
詳細
|
| BML-275 |
6-[4-[2-(1-哌啶基)乙氧基]苯基]-3-(4-吡啶基)吡唑并[1,5-A]嘧啶 |
866405-64-3 |
詳細
|
| LY 294002 |
LY-294,002鹽酸鹽 |
934389-88-5 |
詳細
|
| 4-Chlorothieno[3,2-d]pyrimidine |
4-氯噻吩并[3,2-d]嘧啶 |
16269-66-2 |
詳細
|
| 3-IODO-4-METHOXY-PYRIDIN-2-YLAMINE |
3-碘-4-甲氧基-吡啶-2-胺 |
956485-64-6 |
詳細
|
| LY2603618 |
LY2603618 |
911222-45-2 |
詳細
|
| (5Z)-5-[(2,5-dimethyl-1-pyridin-3-ylpyrrol-3-yl)methylidene]-3-phenyl-1,3-thiazolidine-2,4-dione |
ICRT-14 |
677331-12-3 |
詳細
|
| NSC348884 |
N1,N1,N2,N2-四[(6-甲基-1H-苯并咪唑-2-基)甲基]-1,2-乙二胺 |
81624-55-7 |
詳細
|
| Val-Cit-PAB |
VAL-CIT-PAB |
159857-79-1 |
詳細
|
| SGI-7079 |
3-[2-[[3-氟-4-(4-甲基-1-哌嗪基)苯基]氨基]-5-甲基-7H-吡咯并[2,3-D]嘧啶-4-基]苯乙腈 |
1239875-86-5 |
詳細
|
| Fmoc-Val-Cit-PAB-PNP |
FMoc-Val-Cit-PAB-PNP |
863971-53-3 |
詳細
|
| DCC2701
(Altiratinib) |
ALTIRATINIB |
1345847-93-9 |
詳細
|
| AZ6102 |
REL-2-[4-[6-[(3R,5S)-3,5-二甲基-1-哌嗪基]-4-甲基-3-吡啶基]苯基]-3,7-二氫-7-甲基-4H-吡咯并[2,3-D]嘧啶-4-酮 |
1645286-75-4 |
詳細
|
| BAW2881 |
BAW2881 |
861875-60-7 |
詳細
|
| EPI-001 |
EPI-001 |
227947-06-0 |
詳細
|